Polyclonal Antibody to Parkinson Disease Protein 2 (PARK2) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPL060Hu02-Recombinant Parkinson Disease Protein 2 (PARK2)
Recommended Usage
Western blotting: 0.01-2μg/mL< br/> Immunohistochemistry: 5-20μg/mL< br/> Immunocytochemistry: 5-20μg/mL< br/> Optimal working dilutions must be determined by end user.
